Product Categories
| Country: | China |
|---|---|
| Tel: | 021-58521787 |
| Mobile: | 17701827760 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Azilsartan Medoxomil | C30H24N4O8 | 863031-21-4 | Details |
| Nafamostat Mesylate | C21H25N5O8S2 | 82956-11-4 | Details |
| Tolvaptan | C26H25ClN2O3 | 150683-30-0 | Details |
| Sevelamer carbonate | C7H14ClNO4 | 845273-93-0 | Details |
| Methyl Raloxifene | C29H29NO4S | Details |
| AT-MA | C11H15N3O5S | 74440-02-1 | Details |
| Ticagrelor impurity 1~4 | C23H29FN6O4S | 1643378-47-5 | Details |
| Ticagrelor Impurity 2 | Details |
| Ticagrelor Impurity 4 | Details |
| Sitagliptin racemate | Details |
| S-isomer | C22H26FNO3 | Details |
| Impurity H | Details |
| Silodocin intermediate (239463-85-5) Optical isomer | Details |
| m-Chloride isomer | Details |
| Impurity A | Details |
| Pranoprofen impurity 2 | C15H11NO4 | 52549-19-6 | Details |
| BIBR1155 | C32H36N6O6 | 1408238-37-8 | Details |
| CDBA513BS | Details |
| Oseltamivir impurity 4 | Details |
| Montelukast Sodium | C35H37ClNNaO3S | 151767-02-1 | Details |
| Sertraline Hydrochloride | C17H18Cl3N | 79559-97-0 | Details |
| Dapagliflozin | C21H25ClO6 | 461432-26-8 | Details |
| Empagliflozin | C23H27ClO7 | 864070-44-0 | Details |
| Trimebutine Maleate | C26H33NO9 | 34140-59-5 | Details |
| Entecavir Hydrate | C12H17N5O4 | 209216-23-9 | Details |
| Hydroxyzine Hydrochloride | C21H29Cl3N2O2 | 2192-20-3 | Details |
| Mizolastine | C24H25FN6O | 108612-45-9 | Details |
| Atorvastatin Calcium Anhydrous | C33H37CaFN2O5 | 134523-03-8 | Details |
| Atorvastatin Calcium Trihydrate | C66H74CaF2N4O13 | 344423-98-9 | Details |
| Ezetimibe | C24H21F2NO3 | 163222-33-1 | Details |
| Rosuvastatin Calcium | C22H30CaFN3O6S | 147098-20-2 | Details |
| Amlodipine Besylate | C26H31ClN2O8S | 111470-99-6 | Details |
| Telmisartan | C33H30N4O2 | 144701-48-4 | Details |
| Valsartan | C24H29N5O3 | 137862-53-4 | Details |
| Oseltamivir Phosphate | C16H31N2O8P | 204255-11-8 | Details |
| Eribulin Mesylate | C41H63NO14S | 441045-17-6 | Details |
| Oxaliplatin | C8H12N2O4Pt | 61825-94-3 | Details |
| D-Dapoxetine Hydrochloride | C21H24ClNO | 129938-20-1 | Details |
| Tadalafil | C22H19N3O4 | 171596-29-5 | Details |
| Vardenafil HCl | C23H33ClN6O4S | 224785-91-5 | Details |
| Docusate sodium with Sodium benzoate | C20H37O7S.Na | 577-11-7 | Details |
| Mycophenolate Mofetil | C23H31NO7 | 115007-34-6 | Details |
| Adenine | C5H5N5 | 73-24-5 | Details |
| Dantrolene Na | C14H11N4NaO5 | 14663-23-1 | Details |
| Oxiracetam | C6H10N2O3 | 62613-82-5 | Details |
| Varenicline Tartrate | C17H19N3O6 | 375815-87-5 | Details |
| Mecobalamin | C63H90CoN13O14P | 13422-55-4 | Details |
| Cyanocobalamin | C63H88CoN14O14P | 68-19-9 | Details |
| Pyridoxine hydrochloride | C8H12ClNO3 | 58-56-0 | Details |
| Paricalcitol | C27H44O3 | 131918-61-1 | Details |
| Jaceosidin | Details |
| Imp-1 | Details |
| Diclofenac Epolamine Degradation Impurity 2 | Details |
| Methyl-[E]-2-[3-(S)-[3-[2-(7-chloro-2-quinolinyl)ethenyl]-phenyl]-3-hydroxy-propyl]benzoate | C28H24ClNO3 | 142569-69-5 | Details |
| (S)-1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)ph-enyl)-3-(2-(1-hydroxy-1-methylethyl)-phenyl)propanol | C29H28ClNO2 | 142569-70-8 | Details |
| 3-Trifluoro methyl-[1,2,4]triazole[4,3-a]piperazine hydrochloride | C6H7F3N4.ClH | 762240-92-6 | Details |
| Boc-(R)-3-Amino-4-(2,4,5-trifluoro-phenyl)butanoic acid | C15H18F3NO4 | 486460-00-8 | Details |
| L-1 | C40H47FN2O5 | 125971-95-1 | Details |
| Atorvastatin tert-butyl ester | C37H43FN2O5 | 134395-00-9 | Details |
| (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxo- penyl]-4-phenyl-2- oxazolidinone | C20H18FNO4 | 189028-93-1 | Details |
| 3-[5-(4-fluoro- phenyl)-5-hydroxy- pentanoyl]-5-phenyl- oxazolidin-2-one | C20H20FNO4 | 189028-95-3 | Details |
| Z-9 | C34H34FN3O2PS.Br | 147117-37-4 | Details |
| Tert-Butyl 6-[(1E)-2-[4-(4-fluoro- phenyl)-6-(1-methyl- ethyl)-2-[methyl- (methylsulfonyl)- amino]-5-pyrimidinyl]- ethenyl]-2,2-dimethyl- 1,3-dioxane-4- acetate | C29H40FN3O6S | 289042-12-2 | Details |
| Pranoprofen impurity 3 | Details |
| Imp-2 | C10H11N4O8P-2 | 15386-73-9 | Details |
| Imp-3 | Details |
| DHPCOOMe | Details |
| Dabigatran P-1 | C34H41N7O5 | 211915-06-9 | Details |
| Elagolix intermediate 2 | C13H10F4N2O2 | 830346-47-9 | Details |
| Elagolix intermediate 3 | C13H9F4IN2O2 | 1150560-54-5 | Details |
| Elagolix intermediate 4 | C13H9BrF4N2O2 | 830346-48-0 | Details |
| Elagolix intermediate 5 | C20H15F5N2O3 | 1150560-59-0 | Details |
| Elagolix intermediate 6 | C28H24F5N3O3 | 830346-50-4 | Details |
| Ticagrelor | C23H28F2N6O4S | 274693-27-5 | Details |
| Sitagliptin Phosphate Monohydrate | C16H18F6N5O5P | 654671-77-9 | Details |
| Tenofovir Alafenamide Hemifumarate | C25H33N6O9P | 1392275-56-7 | Details |
| Rebamipide | C19H15ClN2O4 | 90098-04-7 | Details |
| Elagolix | C32H30F5N3O5 | 834153-87-6 | Details |
| Dabigatran Etexilate Mesylate pellet | C35H45N7O8S | 872728-81-9 | Details |
| Green tea extract | C22H18O11 | Details |
| Dried Coptidis Rhizoma Extract | C20H18NO4 | 2086-83-1 | Details |
| Ivy Leaf Extract | Details |
| Artemisia Extract | Details |
| Sitagliptin free base | C16H15F6N5O | 486460-32-6 | Details |
| Tenofovir Alafenamide acid | C15H18N5O4P | 379270-35-6 | Details |
| Tenofovir Alafenamide free base | C21H29N6O5P | 379270-37-8 | Details |
| PMPA | C9H14N5O4P | 147127-20-6 | Details |
| Pranoprofen | C15H13NO3 | 52549-17-4 | Details |
| Trityl Olmesartan acid ethyl ester | C45H44N6O3 | 189400-21-3 | Details |
| Trityl Olmesartan acid | C43H40N6O3 | 761404-85-7 | Details |
| Trityl Olmesartan Medoxomil | C48H44N6O6 | 144690-92-6 | Details |
| Raloxifene parent nucleus | C16H14O2S | 63675-74-1 | Details |
| Raloxifene side chain | C14H20ClNO3 | 84449-80-9 | Details |
| Lesinurad | C17H14BrN3O2S | 878672-00-5 | Details |
| Mono-POC-PMPA | C14H22N5O7P | 211364-69-1 | Details |
| BIBR1150 | C26H33N5O4 | 1408238-36-7 | Details |
| Eupatilin | C18H16O7 | 22368-21-4 | Details |
| Choline Glycerophosphate (GPC) | C8H20NO6P | 28319-77-9 | Details |
| Tenofovir Disoproxil Fumarate | C23H34N5O14P | 202138-50-9 | Details |
| Olmesartan Medoxomil | C29H30N6O6 | 144689-63-4 | Details |
| Silodosin | C25H32F3N3O4 | 160970-54-7 | Details |
| Diclofenac Epolamine | C15H12Cl2O2.C6H13NO | 119623-66-4 | Details |
| Silodosin side chain | C11H13F3O5S | 160969-03-9 | Details |
| Silodosin impurity 3 | C26H31N3O8 | 239463-85-5 | Details |
| Rebamipide amino HCl salt | C12H13ClN2O3 | 132210-24-3 | Details |
| Elagolix intermediate 1 | C9H8F4N2O | 830346-46-8 | Details |
| BIBR951 | C27H29N7O3 | 429658-95-7 | Details |
| Baricitinib | C16H17N7O2S | 1187594-09-7 | Details |
| Jaceosidin | C17H14O7 | 18085-97-7 | Details |
| Deoxycholic acid | C24H40O4 | 83-44-3 | Details |
| Diclofenac Epolamine impurity 3 | C13H11Cl2NO | 27204-57-5 | Details |
| Peramivir | C15H28N4O4 | 229614-55-5 | Details |
| Roxatidine impurity 2 | C19H28N2O7 | 110925-92-3 | Details |
| Tenofovir Disoproxil | C19H30N5O10P | 201341-05-1 | Details |
| Bisacodyl | C22H19NO4 | 603-50-9 | Details |
| Diclofenac Epolamine impurity 1 | C14H9Cl2NO | 15362-40-0 | Details |
| 1-(5-(1H-pyrrol-1-yl)-1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid | Details |
| Pranoprofen impurity C | C17H19NO4 | 143436-36-6 | Details |
| N-Ts Tegoprazan parent nucleus | C18H19N3O4S | 942195-86-0 | Details |
| Roxatidine Acetate HCl | C19H29ClN2O4 | 93793-83-0 | Details |
| Silodosin impurity 1 | C25H32F3N3O4 | 2182279-45-2 | Details |
| Indobufen | C18H17NO3 | 63610-08-2 | Details |
| Indobufen impurity 4 | C18H15NO4 | 94232-67-4 | Details |
| Tegoprazan | C20H19F2N3O3 | 942195-55-3 | Details |
| BIBR1154 | C34H40N6O6 | 1408238-40-3 | Details |
| Sodium Picosulfate impurity B | C18H15NO2 | 603-41-8 | Details |
| Fexuprazan | C19H17F3N2O3S | 1902954-60-2 | Details |
| Rosuvastatin glyceride | Details |
| Indobufen impurity 1 | C18H17NO4 | 76553-18-9 | Details |
| Tegoprazan side chain | C9H8F2O2 | 1270294-05-7 | Details |
| Diclofenac Epolamine impurity 5 | C14H11Cl2NO3 | 69002-84-2 | Details |
| BIBR1087 | C32H37N7O5 | 212321-78-3 | Details |
| Ilaprazole intermediate P-1 | C19H18N4OS | 172152-35-1 | Details |
| Sphingosine | C18H37NO2 | 123-78-4 | Details |
| CDP-Star | C18H19Cl2Na2O7P | 160081-62-9 | Details |
| Crisaborole | C14H10BNO3 | 906673-24-3 | Details |
| d-Toremifene | Details |
| SN32976 | C24H33F2N9O4S | 1246202-11-8 | Details |
| BI-6727 | C34H50N8O3 | 755038-65-4 | Details |
| chlorantraniliprole impurity | C18H12BrCl2N5O | 438450-43-2 | Details |
| PDP-LA | C25H43NO3 | 861891-72-7 | Details |
| BIIB068 | C23H29N7O2 | 1798787-27-5 | Details |
| 5-Pyrimidinecarboxamide, 4-[[2-(hydroxymethyl)phenyl]amino]-2-[(1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinyl)amino]- | C23H26N6O3 | 2739844-28-9 | Details |
| Toremifene | C26H28ClNO | 89778-26-7 | Details |
| Ozagrel impurity-7 | C23H21N2NaO4 | 883903-91-1 | Details |
| Ozagrel methylester | C13H12N2O2 | 866157-50-8 | Details |
| EC5026 | C18H23F4N3O3 | 1809885-32-2 | Details |
| Radezolid | C22H23FN6O3 | 869884-78-6 | Details |
| Clotrimazole | C22H17ClN2 | 23593-75-1 | Details |
| GSK 2256294 | C21H24F3N7O | 1142090-23-0 | Details |
| GDC-0941 | C23H27N7O3S2 | 957054-30-7 | Details |
| UC-1728 | C21H21F3N2O5 | 948304-40-3 | Details |
| TPPU(CS-2462) | C16H20F3N3O3 | 1222780-33-7 | Details |
| CNX1351 | C30H35N7O3S | 1276105-89-5 | Details |
| AZ-20 | C21H24N4O3S | 1233339-22-4 | Details |
| BI-2536 | C28H39N7O3 | 755038-02-9 | Details |
| Ozagrel impurity-C | Details |
| Dexecadotril | C13H18N2 | 13415-07-1 | Details |
| Octahydroaminoacridine | C13H17N9 | 866245-79-6 | Details |
| 2,4'-(2-Pyridylmethylene)diphenol Bis(hydrogen sulfate) Disodium Salt | Details |
| Sodium Picosulfate | C18H13NO8S2.2Na | 10040-45-6 | Details |
| Ozagrel cis isomer impurity-1 | C13H12N2O2 | 143945-86-2 | Details |
| ZSTK474 | C19H21F2N7O2 | 475110-96-4 | Details |
| Landiolol Hydrochloride | C25H40ClN3O8 | 144481-98-1 | Details |
| Raloxifene HCl | C28H28ClNO4S | 82640-04-8 | Details |
| t-AUCB | C24H32N2O4 | 885012-33-9 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||